RecruitingPhase 3NCT05939414
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Sponsor: Novartis Pharmaceuticals
Chicago, IL · Elk Grove, IL · +37 more sites
1 recruiting prostate cancer studies with a site in Elk Grove, IL.
Sponsor: Novartis Pharmaceuticals
Chicago, IL · Elk Grove, IL · +37 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.